You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
瑋俊生物科技(00660.HK)完成根據特定授權發行可換股債券
格隆匯 11-27 08:23

格隆匯 11 月 27日丨瑋俊生物科技(00660.HK)發佈公告,2020年9月21日(於2020年10月27日補充)簽定的認購協議的所有先決條件已獲達成,已於2020年11月27日完成。

股份合併於2020年11月27日生效後及緊接完成前,公司已發行1,659,068,536股合併普通股份。緊隨發行可換股債券後,現時認購人於本金額合計為6700萬港元的可換股債券中擁有權益,並賦予認購人權利以每股股份0.12港元的初始換股價認購558,333,333股換股股份,惟受調整所限。於該公佈日期,並無可換股債券獲轉換。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account